Decreased glutamate transport enhances excitability in a rat model of cortical dysplasia

Neurobiology of Disease

Volumn 32, Issue 2, 2008, Pages 254-261

  Campbell, Susan L ^a   Hablitz, John J ^a  

^a UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

Author keywords

Cortical dysplasia; GLT 1; Glutamate transporters; Neocortex; TBOA

Indexed keywords

AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; DEXTRO 2 AMINO 5 PHOSPHONOVALERIC ACID; DIHYDROKAINIC ACID; GLUTAMATE TRANSPORTER; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; THREO BETA BENZYLOZYASPARTIC ACID; UNCLASSIFIED DRUG;

AMINO ACID TRANSPORT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX LESION; BRAIN NERVE CELL; CONTROLLED STUDY; CORTICAL DYSPLASIA; EPILEPTIC DISCHARGE; EXCITATORY POSTSYNAPTIC POTENTIAL; EXPERIMENTAL MODEL; GLUTAMATE TRANSPORT; MEMBRANE CURRENT; NERVE CELL EXCITABILITY; NEUROTRANSMITTER UPTAKE; NONHUMAN; PRIORITY JOURNAL; RAT;

2-AMINO-5-PHOSPHONOVALERATE; AMINO ACID TRANSPORT SYSTEM X-AG; ANIMALS; ANIMALS, NEWBORN; ASPARTIC ACID; CEREBRAL CORTEX; DISEASE MODELS, ANIMAL; ELECTRIC STIMULATION; EXCITATORY AMINO ACID ANTAGONISTS; KAINIC ACID; MALFORMATIONS OF CORTICAL DEVELOPMENT; MEMBRANE POTENTIALS; NEURONS; PATCH-CLAMP TECHNIQUES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 53749086421     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2008.07.003     Document Type: Article

References (103)

1. Andre V.M., Flores-Hernandez J., Cepeda C., Starling A.J., Nguyen S., Lobo M.K., Vinters H.V., Levine M.S., and Mathern G.W. NMDA receptor alterations in neurons from pediatric cortical dysplasia tissue. Cereb. Cortex. 14 (2004) 634-646
2. Arriza J.L., Fairman W.A., Wadiche J.I., Murdoch G.H., Kavanaugh M.P., and Amara S.G. Functional comparisons of three glutamate transporter subtypes cloned from human motor cortex. J. Neurosci. 14 (1994) 5559-5569
3. Arriza J.L., Eliasof S., Kavanaugh M.P., and Amara S.G. Excitatory amino acid transporter 5, a retinal glutamate transporter coupled to a chloride conductance. Proc. Natl. Acad. Sci. USA. 94 (1997) 4155-4160
4. Bandrowski A.E., Huguenard J.R., and Prince D.A. Baseline glutamate levels affect group I and II mGluRs in layer V pyramidal neurons of rat sensorimotor cortex. J. Neurophysiol. 89 (2003) 1308-1316
5. Baraban S.C., and Schwartzkroin P.A. Electrophysiology of CA1 pyramidal neurons in an animal model of neuronal migration disorders: prenatal methylazoxymethanol treatment. Epilepsy. Res. 22 (1995) 145-156
6. Baraban S.C., and Schwartzkron P.A. Flurothyl seizure susceptibility in rats following prenatal methylazoxymethanol treatment. Epilepsy. Res. 23 (1996) 189-194
7. Barbour B., Keller B.U., Llano I., and Marty A. Prolonged presence of glutamate during excitatory synaptic transmission to cerebellar Purkinje cells. Neuron 12 (1994) 1331-1343
8. Barkovich A.J., and Kjos B.O. Nonlissencephalic cortical dysplasias: correlation of imaging findings with clinical deficits. Am. J. Neuroradiol. 13 (1992) 95-103
9. Barkovich A.J., and Raybaud C.A. Malformations of cortical development. Neuroimag. Clin. N. Am. 14 (2004) 401-423
10. Bianchi L., la Corte L., and Tipton K.F. Simultaneous determination of basal and evoked output levels of aspartate, glutamate, taurine and 4-aminobutyric acid during microdialysis and from superfused brain slices. Journal of Chromatography B: Biomedical Sciences and Applications 723 (1999) 47-59
11. Blanton M.G., Lo Turco J.J., and Kriegstein A.R. Endogenous neurotransmitter activates N-methyl-d-aspartate receptors on differentiating neurons in embryonic cortex. Proc. Natl. Acad. Sci. USA. 87 (1990) 8027-8030
12. Blitzblau R., Gupta S., Djali S., Robinson M.B., and Rosenberg P.A. The glutamate transporter inhibitor l-trans-pyrrolidine-2,4-dicarboxylate indirectly evokes NMDA receptor mediated neurotoxicity in rat cortical cultures. Eur. J. Neurosci. 8 (1996) 1840-1852
13. Bordey A., Lyons S.A., Hablitz J.J., and Sontheimer H.A. Electrophysiological characteristics of reactive astrocytes in experimental cortical dysplasia. J. Neurophysiol. 85 (2001) 1719-1731
14. Brannstrom T., Silvenius H., and Olivecrona M. The range of disorders of cortical organization in surgically treated epilepsy patients. In: Guerrini F., Andermann F., Canapichi R., Roger J., Zifkin B.G., and Pfanner P. (Eds). Dysplasias of Cerebral Cortex and Epilepsy (1996), Lippincott-Raven, Philadelphia 57-64
15. Calcagnotto M.E., and Baraban S.C. Prolonged NMDA-mediated responses, altered ifenprodil sensitivity, and epileptiform-like events in the malformed hippocampus of methylazoxymethanol exposed rats. J. Neurophysiol. 94 (2005) 153-162
16. Campbell S.L., and Hablitz J.J. Glutamate transporters regulate excitability in local networks in rat neocortex. Neuroscience 127 (2004) 625-635
17. Chevassus-au-Louis N., Congar P., Represa A., Ben-Ari Y., and Gaiarsa J.L. Neuronal migration disorders: heterotropic neocortical neurons in CA1 provide a bridge between the hippocampus and the neocortex. Proc. Natl. Acad. Sci. USA. 95 (1998) 10263-10268
18. Choi D.W., Peters S., and Viseskul V. Dextrorphan and levorphanol selectively block N-methyl-d-aspartate receptor-mediated neurotoxicity on cortical neurons. J. Pharmacol. Exp. Ther. 242 (1987) 713-720
19. Choi D.W. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1 (1988) 623-634
20. Conti F., DeBiasi S., Minelli A., Rothstein J.D., and Melone M. EAAC1, a high-affinity glutamate tranporter, is localized to astrocytes and gabaergic neurons besides pyramidal cells in the rat cerebral cortex. Cereb. Cortex. 8 (1998) 108-116
21. Crino P.B., Duhaime A.C., Baltuch G., and White R. Differential expression of glutamate and GABA-A receptor subunit mRNA in cortical dysplasia. Neurology 56 (2001) 906-913
22. Crino B., Hong J., Shumate D., Robinson B., Coulter A., and Brooks-Kayal R. Increased expression of the neuronal glutamate transporter (EAAT3/EAAC1) in hippocampal and neocortical epilepsy. Epilepsia 43 (2002) 211-218
23. Danbolt N.C. Glutamate uptake. Prog. Neurobiol. 65 (2001) 1-105
24. DeFazio T., and Hablitz J.J. Zinc and zolpidem modulate mIPSCs in rat neocortical pyramidal neurons. J. Neurophysiol. 80 (1998) 1670-1677
25. DeFazio R.A., and Hablitz J.J. Reduction of zoldipem sensitivity in a freeze lesion model of neocortical dysgenesis. J. Neurophysiol. 81 (1999) 404-407
26. DeFazio R.A., and Hablitz J.J. Alterations in NMDA receptors in a rat model of cortical dysplasia. J. Neurophysiol. 83 (2000) 315-321
27. Demarque M., Villeneuve N., Manent J.B., Becq H., Represa A., Ben Ari Y., and Aniksztejn L. Glutamate transporters prevent the generation of seizures in the developing rat neocortex. J. Neurosci. 24 (2004) 3289-3294
28. Diamond J.S. Neuronal glutamate transporters limit activation of NMDA receptors by neurotransmitter spillover on CA1 pyramidal cells. J. Neurosci. 21 (2001) 8328-8338
29. During M.J., and Spencer D.D. Extracellular hippocampal glutamate and spontaneous seizure in the conscious human brain. Lancet 341 (1993) 1607-1610
30. Dvorak K., and Feit J. Migration of neuroblasts through partial necrosis of the cerebral cortex in newborn rats: contribution to the problems of morphological development and developmental period of cerebral microgyria. Acta. Neuropathol. 38 (1977) 203-212
31. Dvorak K., Feit J., and Jurankova Z. Experimentally induced focal microgyria and status verrucosus deformis in rats: pathogenesis and interrelation histological and autoradiographical study. Acta. Neuropathol. 44 (1978) 121-129
32. Fairman W.A., Vandenberg R.J., Arriza J.L., Kavanaugh M.P., and Amara S.G. An excitatory amino-acid transporter with properties of a ligand-gated chloride channel. Nature 375 (1995) 599-603
33. Farrell M.A., De Rosa M.J., Curran J.G., Secor D.L., Cornford M.E., Comair Y.G., Peacock W.J., Shields W.D., and Vinters H.V. Neuropathologic findings in cortical resections (including hemispherectomies) performed for the treatment of intractable childhood epilepsy. Acta. Neuropathol. 83 (1992) 246-259
34. Fukamachi S., Furuta A., Ikeda T., Ikenoue T., Kaneoka T., Rothstein J.D., and Iwaki T. Altered expressions of glutamate transporter subtypes in rat model of neonatal cerebral hypoxia-ischemia. Dev. Brain Res. 132 (2001) 131-139
35. Ginsberg S.D., Martin L.J., and Rothstein J.D. Regional deafferentation down-regulates subtypes of glutamate transporter proteins. J. Neurochem. 65 (1995) 2800-2803
36. Hablitz J.J., and DeFazio T. Excitability changes in freeze-induced neocortical microgyria. Epilepsy. Res. 32 (1998) 75-82
37. Hagemann G., Kluska M.M., Redecker C., Luhmann H.J., and Witte O.W. Distribution of glutamate receptor subunits in experimentally induced cortical malformations. Neuroscience 117 (2003) 991-1002
38. Haugeto O., Ullensvang K., Levy L.M., Chaudhry F.A., Honoré T., Nielsen M., Lehre K.P., and Danbolt N.C. Brain glutamate transporter proteins form homomultimers. J. Biol. Chem. 271 (1996) 27715-27722
39. Hestrin S., Sah P., and Nicoll R.A. Mechanisms generating the time course of dual component excitatory synaptic currents recorded in hippocampal slices. Neuron 5 (1990) 247-253
40. Isaacson J.S., and Nicoll R.A. The uptake inhibitor l-trans-PDC enhances responses to glutamate but fails to alter the kinetics of excitatory synaptic currents in the hippocampus. J. Neurophysiol. 70 (1993) 2187-2191
41. Jacobs K.M., Gutnick M.J., and Prince D.A. Hyperexcitability in a model of cortical maldevelopment. Cereb. Cortex. 6 (1996) 514-523
42. Jacobs K.M., Kharazia V.N., and Prince D.A. Mechanisms underlying epileptogenesis in cortical malformations. Epilepsy. Res. 36 (1999) 165-188
43. Jacobs K.M., Hwang B.J., and Prince D.A. Focal epileptogenesis in a rat model of polymicrogyria. J. Neurophysiol. 81 (1999) 159-173
44. Jacobs K.M., and Prince D.A. Excitatory and inhibitory postsynaptic currents in a rat model of epileptogenic microgyria. J. Neurophysiol. 93 (2005) 687-696
45. Janjua N.A., Kabuto H., and Mori A. Increased plasma glutamic acid in a genetic model of epilepsy. Neurochem. Res. 17 (1992) 293-296
46. Jin H., Crino P., and Rikhter T. Increases in EAAC1 glutamate transporter in temporal lobe epilepsy and focal cortical dysplasia. Epilepsia. 41. suppl. 7 (2000) 161-162
47. Kanai Y., and Hediger M.A. Primary structure and functional characterization of a high-affinity glutamate transporter. Nature 360 (1992) 467-471
48. Koch H.P. Differentiation of substrate and nonsubstrate inhibitors of the high-affinity, sodium-dependent glutamate transporters. Mol. Pharmacol. 56 (1999) 1095-1104
49. Koch H.P. Nontransportable inhibitors attenuate reversal of glutamate uptake in synaptosomes following a metabolic insult. Mol. Pharmacol. 55 (1999) 1044-1048
50. Lehre K.P., and Danbolt N.C. The number of glutamate transporter subtype molecules at glutamatergic synapses: Chemical and stereological quantification in young adult rat brain. J. Neurosci. 18 (1998) 8751-8757
51. Lehre K.P., Levy L.M., Ottersen O.P., Storm-Mathisen J., and Danbolt N.C. Differential expression of two glial glutamate transporters in the rat brain: quantitative and immunocytochemical observations. J. Neurosci. 15 (1995) 1835-1853
52. Lipton S.A., and Rosenberg P.A. Excitatory amino acids as a final common pathway for neurologic disorders. N. Engl. J. Med. 330 (1994) 613-622
53. LoTurco J.J., Mody I., and Kriegstein A.R. Differential activation of glutamate receptors by spontaneously released transmitter in slices of neocortex. Neurosci. Lett. 114 (1990) 265-271
54. Luhmann H.J., and Raabe K. Characterization of neuronal migration disorders in neocortical structures: I. Expression of epileptiform activity in an animal model. Epilepsy. Res. 26 (1996) 67-74
55. Luhmann H.J., Karpuk N., Qü M., and Zilles K. Characterization of neuronal migration disorders in neocortical structures. II. Intracellular in vitro recordings. J. Physiol. (Lond). 80 (1998) 92-102
56. Luhmann H.J., Raabe K., Qu M., and Zilles K. Characterization of neuronal migration disorders in neocortical structures: extracellular in vitro recordings. Eur. J. Neurosci. 10 (1998) 3085-3094
57. Marcaggi P., and Attwell D. Role of glial amino acid transporters in synaptic transmission and brain energetics. Glia 47 (2004) 217-225
58. Masliah E., Alford M., Mallory M., Rockenstein E., Moechars D., and Van Leuven F. Abnormal glutamate transport function in mutant amyloid precursor protein transgenic mice. Exp. Neurol. 163 (2000) 381-387
59. Mathern G.W., Mendoza D., Lozada A., Pretorius J.K., Dehnes Y., Danbolt N.C., Nelson N., Leite J.P., Chimelli L., Born D.E., Sakamoto A.C., Assirati J.A., Fried I., Peacock W.J., Ojemann G.A., and Adelson P.D. Hippocampal GABA and glutamate transporter immunoreactivity in patients with temporal lobe epilepsy. Neurology 52 (1999) 453
60. Meldrum B.S. Glutamate as neurotransmitter in the brain: review of physiology and pathology. Journal of Nutrition. 130 4S Suppl (2000) S1007-S1015
61. Meldrum B.S., Akbar M.T., and Chapman A.G. Glutamate receptors and transporters in genetic and acquired models of epilepsy. Epilepsy. Res. 36 (1999) 189-204
62. Mikuni N., Babb T.L., Ying Z., Najm I., Nishiyama K., Wylie C., Yacubova K., Okamoto T., and Bingaman W. NMDA-receptors 1 and 2A/B coassembly increased in human epileptic focal cortical dysplasia. Epilepsia 40 (1999) 1683-1687
63. Miller H.P., Levey A.I., Rothstein J.D., Tzingounis A.V., and Conn P.J. Alterations in glutamate transporter protein levels in kindling-induced epilepsy. J. Neurochem. 68 (1997) 1564-1570
64. Milton I.D., Banner S.J., Ince P.G., Piggott N.H., Fray A.E., Thatcher N., Horne C.H.W., and Shaw P.J. Expression of the glial glutamate transporter EAAT2 in the human CNS:An immunohistochemical study. Mol. Brain Res. 52 (1997) 17-31
65. Minamoto Y., Itano T., Tokuda M., Matsui H., Janjua N.A., Hosokawa K., Okada Y., Murakami T.H., Negi T., and Hatase O. In vivo microdialysis of amino acid neurotransmitters in the hippocampus in amygdaloid kindled rat. Brain Res. 573 (1992) 345-348
66. Mischel P.S., Nguyen L.P., and Vinters H.V. Cerebral cortical dysplasia associated with pediatric epilepsy: review of neuropathologic features and proposal for a grading system. J. Neuropath. Exp. Neur. 54 (1995) 137-153
67. Najm I.M., Ying Z., Babb T., Mohamed A., Hadam J., LaPresto E., Wyllie E., Kotagal P., Bingaman W., Foldvary N., Morris H., and Luders H.O. Epileptogenicity correlated with increased N-methyl-d-aspartate receptor subunit NR2A/B in human focal cortical dysplasia. Epilepsia 41 (2000) 971-976
68. Nicholls D., and Attwell D. The release and uptake of excitatory amino acids. Trends Pharmacol. Sci. 11 (1990) 462-468
69. Olivier A., Andermann F., Palmini A., and Robitaille Y. Surgical treatment of the cortical dysplasias. In: Guerrini R., Andermann F., Canapicchi R., Roger J., Zifkin B.G., and Pfanner P. (Eds). Dysplasias of Cerebral Cortex and Epilepsy (1996), Lippincott-Raven, Philadelphia 351-366
70. Olney J.W., and Ho O.L. Brain damage in infant mice following oral intake of glutamate, aspartate or cysteine. Nature 227 (1970) 609-611
71. Otis T.S., Wu Y.C., and Trussell L.O. Delayed clearance of transmitter and the role of glutamate transporters at synapses with multiple release sites. J. Neurosci. 16 (1996) 1634-1644
72. Overstreet L.S., Kinney G.A., Liu Y.B., Billups D., and Slater N.T. Glutamate transporters contribute to the time course of synaptic transmission in cerebellar granule cells. J. Neurosci. 19 (1999) 9663-9673
73. Palay S.L., and Chan-Palay V. Cerebellar Cortex-Cytology and Organization (1974), Springer, Berlin
74. Palmini A., Andermann F., Olivier A., Tampieri D., and Robitaille Y. Focal neuronal migration disorders and intractable partial epilepsy: results of surgical treatment. Ann. Neurol. 30 (1991) 750-757
75. Palmini A., Andermann E., Aicardi J., Dulac O., Chaves F., Ponsot G., Pinard J.M., Goutieres F., Livingston J., and Tampieri D. Diffuse cortical dysplasia, or the 'double cortex' syndrome: the clinical and epileptic spectrum in 10 patients. Neurology 41 (1991) 1656-1662
76. Peghini P., Janzen J., and Stoffel W. Glutamate transporter EAAC-1-deficient mice develop dicarboxylic aminoaciduria and behavioral abnormalities but no neurodegeneration. EMBO J. 16 (1997) 3822-3832
77. Perry T.L., and Hansen S. Amino acid abnormalities in epileptogenic foci. Neurology 31 (1981) 872-876
78. Pines G., Danbolt N.C., Bjørås M., Zhang Y., Bendahan A., Eide L., Koepsell H., Storm-Mathisen J., Seeberg E., and Kanner B.I. Cloning and expression of a rat brain l-glutamate transporter. Nature 360 (1992) 464-467
79. Porter B.E., Judkins A.R., Clancy R.R., Duhaime A., Dlugos D.J., and Golden J.A. Dysplasia: a common finding in intractable pediatric temporal lobe epilepsy. Neurology 61 (2003) 365-368
80. Prayson R.A., and Estes M.L. Cortical dysplasia: a histopathologic study of 52 cases of partial lobectomy in patients with epilepsy. Hum. Pathol. 26 (1995) 493-500
81. Prince D.A., Jacobs K.M., Salin P.A., Hoffman S., and Parada I. Chronic focal neocortical epileptogenesis: does disinhibition play a role?. Can. J. Physiol. Pharmacol. 75 (1997) 500-507
82. Proper E.A., Hoogland G., Kappen S.M., Jansen G.H., Rensen M.G.A., Schrama L.H., van Veelen C.W.M., van Rijen P.C., van Nieuwenhuizen O., Gispen W.H., and de Graan P.N.E. Distribution of glutamate transporters in the hippocampus of patients with pharmaco-resistant temporal lobe epilepsy. Brain 125 (2002) 32-43
83. Raymond A.A., Fish D.R., Sisodiya S.M., Alsanjari N., Stevens J.M., and Shorvon S.D. Abnormalities of gyration, heterotopias, tuberous sclerosis, focal cortical dysplasia, microdysgenesis, dysembryoplastic neuroepithelial tumour and dysgenesis of the archicortex in epilepsy: clinical, EEG and neuroimaging features in 100 adult patients. Brain 118 (1995) 629-660
84. Redecker C., Lutzenburg M., Gressens P., Evrard P., Witte O.W., and Hagemann G. Excitability changes and glucose metabolism in experimentally induced focal cortical dysplasias. Cereb. Cortex. 8 (1998) 623-634
85. Roper S.N. In utero irradiation of rats as a model of human cerebrocortical dysgenesis: a review. Epilepsy. Res. 32 (1998) 63-74
86. Rothstein J.D., Martin L., Levey A.I., Dykes-Hoberg M., Jin H., Wu D., Nash N., and Kuncl R.W. Localization of neuronal and glial glutamate transporters. Neuron 13 (1994) 713-725
87. Rothstein J.D., Dykes-Hoberg M., Pardo C.A., Bristol L.A., Jin L., Kuncl R.W., Kanai Y., Hediger M.A., Wang Y., Schielke J.P., and Welty D.F. Knockout of glutamate transporters reveals a major role for astroglial transport in excitatory and clearance of glutamate. Neuron 16 (1996) 675-686
88. Rusakov D.A., and Kullmann D.M. Extrasynaptic glutamate diffusion in the hippocampus: ultrastructural constraints, uptake, and receptor activation. J. Neurosci. 18 (1998) 3158-3170
89. Sarantis M., Ballerini L., Miller B., Silver R.A., Edwards M., and Attwell D. Glutamate uptake from the synaptic cleft does not shape the decay of the non-NMDA component of the synaptic current. Neuron 11 (1993) 541-549
90. Sherwin A., Robitaille Y., Quesney F., Olivier A., Villemure J., Leblanc R., Feindel W., Andermann E., Gotman J., Andermann F., Ethier R., and Kish S. Excitatory amino acids are elevated in human epileptic cerebral cortex. Neurology 38 (1988) 920-923
91. Spacek J. Three-dimensional analysis of dendritic spines. III. Glial sheath. Anat. Embryol. 171 (1985) 245-252
92. +-dependent glutamate/aspartate transporter from rat brain. Proc. Natl. Acad. Sci. USA. 89 (1992) 10955-10959
93. Sah P., Hestrin S., and Nicoll R.A. Tonic activation of NMDA receptors by ambient glutamate enhances excitability of neurons. Science 246 (1989) 815-818
94. Sutor B., and Hablitz J.J. Cholinergic modulation of epileptiform activity in the developing rat neocortex. Dev. Brain Res. 46 (1989) 155-160
95. Takahashi M., Billups B., Rossi D., Sarantis M., Hamann M., and Attwell D. Pre- and postsynaptic determinants of EPSC waveform at cerebellar climbing fiber and parallel fiber to Purkinje cell synapses. J. Neurosci. 15 (1995) 5693-5702
96. Tanaka K., Watase K., Manabe T., Yamada K., Watanabe M., Takahashi K., Iwama H., Nishikawa T., Ichihara N., Kikuchi T., Okuyama S., Kawashima N., Hori S., Takimoto M., and Wada K. Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. Science 276 (1997) 1699-1702
97. Tong G., and Jahr C. Block of glutamate transporters potentiates postsynaptic excitation. Neuron 13 (1994) 1195-1203
98. Ventura R., and Harris K.M. Three-dimensional relationships between hippocampal synapses and astrocytes. J. Neurosci. 19 (1999) 6897-6906
99. Watanabe T., Morimoto K., Hirao T., Suwaki H., Watase K., and Tanaka K. Amygdala-kindled and pentylenetetrazole-induced seizures in glutamate transporter GLAST-deficient mice. Brain Res. 845 (1999) 92-96
100. White R., Hua Y., Scheithauer B., Lynch D., Henske E., and Crino P. Selective alterations in glutamate and GABA receptor subunit mRNA expression in dysplastic neurons and giant cells of cortical tubers. Ann. Neurol. 49 (2001) 67-68
101. Williams K. Ifenprodil discriminates subtypes of the N-methyl-d-asparatate receptor: Selectivity and mechanisms at recombinant heteromeric receptors. Mol. Pharmacol. 44 (1993) 851-859
102. Zhang W.Q., Hudson P.M., Sobotka T.J., Hong J.S., and Tilson H.A. Extracellular concentrations of amino acid transmitters in ventral hippocampus during and after the development of kindling. Brain Res. 540 (1991) 315-318
103. Zilles K., Qu M., Schleicher A., and Luhmann H.J. Characterization of neuronal migration disorders in neocortical structures: quantitative receptor autoradiography of ionotropic glutamate, GABAA and GABAB receptors. Eur J Neurosci 10 (1998) 3095-3106